Literature DB >> 25589302

Adrenal Insufficiency as a Result of Ritonavir and Exogenous Steroid Exposure: Report of 6 Cases and Recommendation for Management.

Brian R Wood1, John Matthew Lacy2, Christine Johnston3, David S Weigle4, Shireesha Dhanireddy3.   

Abstract

Numerous cases of Cushing syndrome have been reported as a result of the interaction between ritonavir (RTV) and exogenous steroid medications. Another complication that frequently occurs is secondary adrenal insufficiency, which can be profound and has not been well described. Here, we report 6 cases of adrenal suppression caused by RTV and exogenous steroids, all of which required corticosteroid replacement therapy and 2 of which were severe enough to require hospitalization. These cases add to the body of literature on the dangerous interaction between RTV and corticosteroids and highlight the risk of secondary adrenal suppression. We also review the literature on this complication and make a recommendation for managing and monitoring such cases.
© The Author(s) 2015.

Entities:  

Keywords:  Cushing syndrome; HIV; adrenal insufficiency; glucocorticoids; ritonavir

Mesh:

Substances:

Year:  2015        PMID: 25589302     DOI: 10.1177/2325957414567681

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  7 in total

1.  Rebound adrenal insufficiency after withdrawal of ritonavir in a 65-year-old man using inhaled budesonide.

Authors:  Olivier Veilleux; Todd C Lee; Emily G McDonald
Journal:  CMAJ       Date:  2017-09-18       Impact factor: 8.262

2.  Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.

Authors:  Emilie R Elliot; Aikaterini Theodoraki; Lakshmi R Jain; Neal J Marshall; Marta Boffito; Stephanie E Baldeweg; Laura J Waters
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

Review 3.  Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

Authors:  Laure Elens; Loralie J Langman; Dennis A Hesselink; Stein Bergan; Dirk Jan A R Moes; Mariadelfina Molinaro; Raman Venkataramanan; Florian Lemaitre
Journal:  Ther Drug Monit       Date:  2020-06       Impact factor: 3.681

4.  Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test.

Authors:  René Rodríguez-Gutiérrez; Adrian Rendon; Maximiliano Barrera-Sánchez; Kevin Erick Gabriel Carlos-Reyna; Neri Alejandro Álvarez-Villalobos; Gloria González-Saldivar; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2016-02-23       Impact factor: 3.257

5.  Iatrogenic Cushing syndrome and multifocal osteonecrosis caused by the interaction between inhaled fluticasone and ritonavir.

Authors:  Joana Figueiredo; Margarida Serrado; Nikita Khmelinskii; Sónia do Vale
Journal:  BMJ Case Rep       Date:  2020-05-27

6.  Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.

Authors:  A M Berton; N Prencipe; R Giordano; E Ghigo; S Grottoli
Journal:  J Endocrinol Invest       Date:  2020-06-08       Impact factor: 4.256

Review 7.  What we have to know about corticosteroids use during Sars-Cov-2 infection.

Authors:  F Ferraù; F Ceccato; S Cannavò; C Scaroni
Journal:  J Endocrinol Invest       Date:  2020-08-28       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.